| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.04 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |